论文部分内容阅读
本文对湖南省14所地市级医院1997年药品使用情况，运用药物经济学费用一效益分析方法进行动态分析，并与国内同级医院比较。认为1997年14家医院药品费用增长幅度已明显降低，而且低于全国水平及其它医疗业务费用增长速度；卫生事业经费持续增长的首要原因是其它医疗收入（如检查、治疗）增长过快，其次才是药品费用的增长;药品费用（收入）所占医院业务收入比例的多少并不能确切反映医疗水平高低，亦不能确切地反映医院效益的优劣。要保证药品费用一效益，既不能放纵药品使用，也不能鼓励提高其它医疗业务收入（如各种检查），压抑药品使用。以期探讨一套较为科学的药品费用一效益评价指标。
In this paper, Hunan Province, 14 municipal hospitals in 1997 the use of drugs, the use of drug economics cost-benefit analysis of a dynamic analysis and comparison with the domestic hospitals at the same level. It is considered that the growth rate of drug expenses in 14 hospitals in 1997 was significantly lower than that of the national level and the growth rate of other medical service expenses. The primary reason for the sustained increase in the funding for health care was the rapid growth of other medical revenues (such as examination and treatment), followed by Is the increase in the cost of medicine; how much of the proportion of the cost of medicine (income) in the hospital’s business revenue does not exactly reflect the level of medical care, nor does it accurately reflect the advantages and disadvantages of the hospital’s benefits. To ensure the effectiveness of drug costs, we can neither indulge the use of drugs nor encourage other medical services (such as various tests) to suppress the use of drugs. In order to explore a set of more scientific medicine cost-benefit evaluation index.